June 26 was a groundbreaking day for the US cannabis industry.
That’s the day the FDA, the US agency responsible for approving new drug candidates, approved its first-ever cannabis drug.
The first-ever medical treatment derived from a marijuana plant will hit the U.S. market in a few months after regulators on Monday gave the epilepsy treatment the green light.
The Food and Drug Administration approved GW Pharmaceuticals Plc’s Epidiolex to treat two rare forms of childhood epilepsy, according to a statement from the agency. The liquid is made from a compound in the marijuana plant called cannabidiol, a different chemical from tetrahydrocannabinol, or THC, which gets users high.
Due to restrictive federal banking regulations, cannabis dispensaries are known to operate with large amounts of cash.
Copious amounts of cash have attracted criminal activity to the industry.
For example, in 2016 a security guard at a Colorado dispensary was killed.
In late summer 2017, a cannabis dispensary in San Fransisco was robbed of $600,000 in cannabis products.
Police say these kind of robberies are becoming more common.
If you poke around on the Internet, you will find hundreds of stories about criminals targeting cannabis dispensaries for cash and product.
Until the US cannabis industry is free from these restrictive federal banking regulations, cannabis dispensaries remain as hot targets for criminals.
While this is a speed bump in the long-term growth potential of the US cannabis industry, it's also creating a significant opportunity for a former military security specialist and his promising security company.